文献速递免疫规划卫生政策与健康促进

流感疫苗病毒与季节性疫苗研发:日本视角

Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective.
PubMed 文献 · Vaccine · 2023-06-07

日本厚生劳动省为四价季节性流感疫苗各组分指定特定病毒株,四家国内厂商用统一毒株生产同配方鸡蛋基灭活裂解疫苗。2017年发现抗原性相似但产量低的候选株不适合生产,2018年改革毒株选择方案并委托疫苗流行病学研究组探讨选择方法。本文总结2018年第22届日本疫苗学会年会研讨会内容,涵盖毒株选择现状、疫苗评价及新配方研发,并提及2022年3月起讨论外国厂商季节性流感疫苗的优劣。

要点

  • 日本厚生劳动省为四价季节性流感疫苗各组分指定特定病毒株,四家国内厂商用统一毒株生产鸡蛋基灭活裂解疫苗。
  • 2017年发现抗原性相似但产量低的候选疫苗株不适合生产,2018年改革毒株选择方案并委托疫苗流行病学研究组探讨选择方法。
  • 2022年3月起厚生劳动省开始讨论外国厂商生产季节性流感疫苗的优劣。

核心结论

  • 日本厚生劳动省2018年改革疫苗株选择方案,并委托疫苗流行病学研究组探讨季节性流感疫苗病毒株的选择方法。

研究设计与样本

  • 本文为研讨会报告,总结2018年第22届日本疫苗学会年会「当前季节性流感疫苗的问题与未来展望」研讨会内容。

主要发现

  • 2017年日本疫苗病毒选择体系显示,即使候选疫苗病毒与预测流行病毒抗原性相似,也可能因产量低而不适合疫苗生产。

关键数值与推荐

  • 日本厚生劳动省为四价季节性流感疫苗各组分指定一种特定病毒株,四家国内厂商使用统一疫苗株生产同配方鸡蛋基灭活裂解疫苗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In Japan, the Ministry of Health, Labour and Welfare (MHLW) designates one specific virus strain for each component of the quadrivalent seasonal influenza vaccine, and four domestic manufacturers produce egg-based influenza vaccines with the same formulation (inactivated, split-virus) using uniform vaccine strains. Thus, discussions of the development of effective seasonal influenza vaccines so far has focused solely on the antigenic match between the vaccine strains and epidemic viruses. However, in 2017, the Japanese selection system of vaccine viruses demonstrated that even a candidate vaccine virus that is antigenically similar to the predicted circulating viruses is not necessarily suitable for vaccine production, given lower productivity of the vaccine. Taking this experience into account, the MHLW reformed the scheme of vaccine strain selection in 2018, and instructed the Vaccine Epidemiology Research Group created by the MHLW to probe how the virus strains for the seasonal influenza vaccine should be selected in Japan. In this context, a symposium, entitled "Issues of the Present Seasonal Influenza Vaccines and Future Prospects", was held as part of the 22nd Annual Meeting of the Japanese Society for Vaccinology in 2018, and subjects related to the influenza vaccine viruses were discussed among relevant administrators, manufacturers, and researchers. This report summarizes the presentations given at that symposium in order to convey the present scheme of vaccine virus selection, the evaluation of the resulting vaccines, and the efforts at new vaccine formulation in Japan. Notably, from March 2022, the MHLW has launched a discussion of the merits of the seasonal influenza vaccines produced by foreign manufacturers.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kato H, Hozawa T, Fukushima W, et al. Influenza vaccine viruses and the development of seasonal vaccines: A Japanese perspective. Vaccine. 2023. PMID: 37291024. doi:10.1016/j.vaccine.2023.05.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。